Health News Highlights: Bird Flu Cases, Infant Formula Trials, and Abortion Access
Recent health news includes Oregon identifying three cases of bird flu in Washington farm workers, Abbott and Reckitt securing legal victory in infant formula trials, and significant developments in abortion access impacting U.S. state supreme court races. Additionally, Novo's weight-loss drug trial shows promise against fatty liver disease, among other topics.
Three individuals in Oregon have tested positive for bird flu after exposure to infected poultry in Washington, marking a rise in U.S. cases. This highlights ongoing concerns about the virus's impact on health and agriculture.
Abbott Laboratories and Reckitt's unit Mead Johnson achieved a significant legal victory as a jury ruled them not responsible for a child's intestinal disease in a trial over premature baby formulas. This favorable outcome boosted Abbott's market shares significantly.
Abortion rights continue to shape U.S. state supreme court races following the Roe v. Wade reversal, with several states challenging or upholding restrictions. Concurrently, Louisiana faces lawsuits over classifying abortion pills as controlled substances.
(With inputs from agencies.)
ALSO READ
Novo Nordisk's CagriSema Trial Aims for Enhanced Weight-Loss Results in 2025
Novo Nordisk Plans New CagriSema Trial After Setback
Novo Nordisk Faces Setback as Obesity Drug Trial Falls Short
Novo Nordisk's Setback: CagriSema's Disappointing Trial Results Shake Market Value
Novo Nordisk's $125 Billion Setback: CagriSema's Trial Disappointment